Outcome from an ITF EMA meeting of PRISMAP (quality requirements for new radionuclides in clinical trials)
Outcome from an ITF EMA meeting of PRISMAP (quality requirements for new radionuclides in clinical trials)
Abstract
Outcome from an ITF EMA meeting of PRISMAP (quality requirements for new radionuclides in clinical trials)
-
Eingeladener Vortrag (Konferenzbeitrag)
21st European Symposium on Radiopharmacy & Radiopharmaceuticals ESRR'24, 18.-21.04.2024, Coimbra, Portugal
Permalink: https://www.hzdr.de/publications/Publ-38791
